Myeloid Therapeutics
Clinical trials sponsored by Myeloid Therapeutics, explained in plain language.
-
New hope for advanced liver cancer: first human trial of MT-303 begins
Disease control Recruiting nowThis early-stage trial tests a new drug called MT-303 in about 70 adults with advanced liver cancer that has spread or cannot be removed. The study aims to find a safe dose and see if the drug works, both alone and with other cancer medicines. Participants must have a specific ma…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New drug MT-304 targets Hard-to-Treat HER2 cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called MT-304, given alone or with another drug (nivolumab), in adults with advanced HER2-expressing solid tumors. The main goals are to check safety and find the best dose. About 60 participants will receive the treatment every two to four…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated May 05, 2026 11:53 UTC